Abstract
Cardiovascular disease --an age-related disease-- is the leading cause of death worldwide. We built an arterial age predictor by training deep learning models to predict age from 233,388 pulse wave analysis records, 8,279 carotid ultrasound images and arterial health biomarkers (e.g blood pressure) collected from 502,000 UKB participants. We predicted age with a R-Squared of 67.1+/-0.6% and a root mean squared error of 4.29+/-0.04 years. Attention maps for carotid ultrasound images suggest that the predictions are driven by vascular features, for the largest part. Accelerated arterial aging is 32.6+/-7.3% GWAS-heritable, and we identified 192 single nucleotide polymorphisms in 109 genes (e.g NPR3, involved in blood volume and pressure) significantly associated with this phenotype. Similarly, we identified biomarkers (e.g electrocardiogram features), clinical phenotypes (e.g chest pain), diseases (e.g hypertension), environmental (e.g smoking) and socioeconomic (e.g income and education) variables associated with accelerated arterial aging. Finally, carotid ultrasound images, pulse wave analysis records and blood pressure biomarkers capture different facets of arterial aging. For example, carotid ultrasound-measured and pulse wave analysis-measured accelerated arterial aging phenotypes are only .164+/-.009 correlated. In conclusion, our predictor suggests potential lifestyle and therapeutic interventions to slow arterial aging, and could be used to assess the efficiency of emerging rejuvenating therapies on the arterial system.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding: NIEHS R00 ES023504; NIEHS R21 ES25052; NIAID R01 AI127250; NSF 163870; MassCATS, Massachusetts Life Science Center; Sanofi. The funders had no role in the study design or drafting of the manuscript(s).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Harvard internal review board (IRB) deemed the research as non-human subjects research (IRB: IRB16-2145).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used the UK Biobank (project ID: 52887). The main code can be found at https://github.com/Deep-Learning-and-Aging. The code for survival prediction can be found at: The code for the survival analysis can be found at https://github.com/alanlegoallec/Deep_survival_from_time_series. The results can be interactively and extensively explored at https://www.multidimensionality-of-aging.net/. We will make the biological age phenotypes available through UK Biobank upon publication. The GWAS results can be found at https://www.dropbox.com/s/59e9ojl3wu8qie9/Multidimensionality_of_aging-GWAS_results.zip?dl=0.
https://github.com/Deep-Learning-and-Aging
https://github.com/alanlegoallec/Deep_survival_from_time_series
https://www.multidimensionality-of-aging.net/
https://www.dropbox.com/s/59e9ojl3wu8qie9/Multidimensionality_of_aging-GWAS_results.zip?dl=0
